Anavex Life Sciences宣布发表口服Blarcamesine研究论文,描述来自阿尔茨海默病II期b/III期试验的新型临床精准医学

美股速递
Sep 30, 2025

Anavex Life Sciences宣布发表口服Blarcamesine研究论文,描述来自阿尔茨海默病II期b/III期试验的新型临床精准医学。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10